Stifel Financial
IOVA icon

Stifel Financial’s Iovance Biotherapeutics IOVA Stock Holding History

Stifel Financial’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$876K Sell
210,515
-239,124
-53% -$908K ﹤0.01% 2640
2026
Q1 		$1.58M Buy
449,639
+119,824
+36% +$383K ﹤0.01% 2127
2025
Q4 		$900K Sell
329,815
-19,780
-6% -$45.8K ﹤0.01% 2511
2025
Q3 		$759K Buy
349,595
+123,955
+55% +$293K ﹤0.01% 2560
2025
Q2 		$388K Buy
225,640
+60,816
+37% +$151K ﹤0.01% 2910
2025
Q1 		$549K Sell
164,824
-45,175
-22% -$233K ﹤0.01% 2625
2024
Q4 		$1.55M Sell
209,999
-13,108
-6% -$122K ﹤0.01% 1955
2024
Q3 		$2.09M Buy
223,107
+58,787
+36% +$557K ﹤0.01% 1736
2024
Q2 		$1.32M Sell
164,320
-93,975
-36% -$1.01M ﹤0.01% 1991
2024
Q1 		$3.83M Sell
258,295
-50,459
-16% -$587K ﹤0.01% 1307
2023
Q4 		$2.51M Buy
308,754
+78,600
+34% +$411K ﹤0.01% 1518
2023
Q3 		$1.05M Sell
230,154
-96,179
-29% -$628K ﹤0.01% 2023
2023
Q2 		$2.3M Buy
326,333
+177,440
+119% +$1.27M ﹤0.01% 1537
2023
Q1 		$910K Buy
148,893
+10,968
+8% +$75.7K ﹤0.01% 2121
2022
Q4 		$881K Buy
+137,925
New +$1.08M ﹤0.01% 2092
2021
Q4 		– Sell
-8,735
Closed -$215K – 3411
2021
Q3 		$215K Buy
8,735
+135
+2% +$3.18K ﹤0.01% 3097
2021
Q2 		$224K Sell
8,600
-18,702
-69% -$486K ﹤0.01% 3076
2021
Q1 		$864K Sell
27,302
-4,916
-15% -$204K ﹤0.01% 2090
2020
Q4 		$1.5M Buy
32,218
+941
+3% +$37.4K ﹤0.01% 1566
2020
Q3 		$1.03M Buy
31,277
+1,050
+3% +$32.2K ﹤0.01% 1608
2020
Q2 		$830K Sell
30,227
-2,183
-7% -$71.8K ﹤0.01% 1698
2020
Q1 		$969K Sell
32,410
-6,970
-18% -$185K ﹤0.01% 1464
2019
Q4 		$1.09M Buy
+39,380
New +$896K ﹤0.01% 1764

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Stifel Financial's IOVA Position: Q2 2026 in Review

Stifel Financial reduced its Iovance Biotherapeutics (IOVA) stake by 53% in Q2 2026, selling an estimated $908K and leaving 210,515 shares worth $876K. The position accounts for ﹤0.01% of the portfolio, ranked #2640.

Stifel Financial first reported a position in IOVA in Q4 2019 and has held it in 23 quarters since. The position peaked at $3.83M in Q1 2024. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Stifel Financial held 210,515 shares of Iovance Biotherapeutics worth $876K as of Q2 2026.
  • Stifel Financial sold 239,124 Iovance Biotherapeutics shares in Q2 2026, an estimated $908K.
  • Iovance Biotherapeutics made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2640 holding.
  • Stifel Financial first reported a position in Iovance Biotherapeutics in Q4 2019 and has held it in 23 quarters since.
  • Stifel Financial's Iovance Biotherapeutics position peaked at $3.83M in Q1 2024.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.